Cora Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $277K | Sell |
3,964
-244
| -6% | -$17.1K | 0.12% | 85 |
|
|
2025
Q1 | $309K | Buy |
4,208
+12
| +0.3% | +$882 | 0.15% | 75 |
|
|
2024
Q4 | $275K | Buy |
4,196
+12
| +0.3% | +$786 | 0.13% | 81 |
|
|
2024
Q3 | $326K | Hold |
4,184
| – | – | 0.16% | 71 |
|
|
2024
Q2 | $326K | Sell |
4,184
-2
| -0% | -$156 | 0.17% | 67 |
|
|
2024
Q1 | $284K | Hold |
4,186
| – | – | 0.15% | 73 |
|
|
2023
Q4 | $282K | Sell |
4,186
-56
| -1% | -$3.77K | 0.17% | 75 |
|
|
2023
Q3 | $287K | Sell |
4,242
-5
| -0.1% | -$339 | 0.19% | 71 |
|
|
2023
Q2 | $304K | Sell |
4,247
-81
| -2% | -$5.8K | 0.2% | 69 |
|
|
2023
Q1 | $300K | Buy |
4,328
+23
| +0.5% | +$1.6K | 0.22% | 62 |
|
|
2022
Q4 | $292K | Buy |
+4,305
| New | +$292K | 0.2% | 58 |
|